Kong X - Search Results

1

Prognostic Alternative mRNA Splicing Signature and a Novel Biomarker in Triple-Negative Breast Cancer.

Liu Q, Wang X, Kong X, Yang X, Cheng R, Zhang W, Gao P, Chen L, Wang Z, Fang Y, Wang J. Liu Q, et al. Among authors: kong x. DNA Cell Biol. 2020 Jun;39(6):1051-1063. doi: 10.1089/dna.2020.5460. Epub 2020 Apr 30. DNA Cell Biol. 2020. PMID: 32379494

2

A meta-analysis: Is there any association between MiR-608 rs4919510 polymorphism and breast cancer risks?

Wang J, Kong X, Xing Z, Wang X, Zhai J, Fang Y, Gao J. Wang J, et al. Among authors: kong x. PLoS One. 2017 Aug 22;12(8):e0183012. doi: 10.1371/journal.pone.0183012. eCollection 2017. PLoS One. 2017. PMID: 28829821 Free PMC article.

3

Roles and expression profiles of long non-coding RNAs in triple-negative breast cancers.

Kong X, Liu W, Kong Y. Kong X, et al. Among authors: kong y. J Cell Mol Med. 2018 Jan;22(1):390-394. doi: 10.1111/jcmm.13327. Epub 2017 Sep 22. J Cell Mol Med. 2018. PMID: 28941134 Free PMC article. Review.

4

Association between SORL1 polymorphisms and the risk of Alzheimer's disease.

Cong L, Kong X, Wang J, Du J, Xu Z, Xu Y, Zhao Q. Cong L, et al. Among authors: kong x. J Integr Neurosci. 2018;17(2):185-192. doi: 10.31083/JIN-170051. J Integr Neurosci. 2018. PMID: 29036834 Review.

5

An uncommon granulocytic sarcoma of the breast: a case report and literature review.

Zhai J, Kong X, Yang X, Gao J, Xuan L, Wang X, Wang J, Fang Y. Zhai J, et al. Among authors: kong x. Onco Targets Ther. 2018 Jun 25;11:3685-3690. doi: 10.2147/OTT.S149149. eCollection 2018. Onco Targets Ther. 2018. PMID: 29983576 Free PMC article.

6

Immunological therapy: A novel thriving area for triple-negative breast cancer treatment.

Wang X, Qi Y, Kong X, Zhai J, Li Y, Song Y, Wang J, Feng X, Fang Y. Wang X, et al. Among authors: kong x. Cancer Lett. 2019 Feb 1;442:409-428. doi: 10.1016/j.canlet.2018.10.042. Epub 2018 Nov 9. Cancer Lett. 2019. PMID: 30419345 Review.

7

Expression signatures and roles of microRNAs in inflammatory breast cancer.

Qi Y, Wang X, Kong X, Zhai J, Fang Y, Guan X, Wang J. Qi Y, et al. Among authors: kong x. Cancer Cell Int. 2019 Jan 31;19:23. doi: 10.1186/s12935-018-0709-6. eCollection 2019. Cancer Cell Int. 2019. PMID: 30733644 Free PMC article. Review.

8

Recent Advances in Understanding FOXN3 in Breast Cancer, and Other Malignancies.

Kong X, Zhai J, Yan C, Song Y, Wang J, Bai X, Brown JAL, Fang Y. Kong X, et al. Front Oncol. 2019 May 31;9:234. doi: 10.3389/fonc.2019.00234. eCollection 2019. Front Oncol. 2019. PMID: 31214487 Free PMC article. Review.

9

Artificial intelligence: a key to relieve China's insufficient and unequally-distributed medical resources.

Kong X, Ai B, Kong Y, Su L, Ning Y, Howard N, Gong S, Li C, Wang J, Lee WT, Wang J, Kong Y, Wang J, Fang Y. Kong X, et al. Among authors: kong y. Am J Transl Res. 2019 May 15;11(5):2632-2640. eCollection 2019. Am J Transl Res. 2019. PMID: 31217843 Free PMC article. Review.

10

LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1.

Ai B, Kong X, Wang X, Zhang K, Yang X, Zhai J, Gao R, Qi Y, Wang J, Wang Z, Fang Y. Ai B, et al. Among authors: kong x. Cell Death Dis. 2019 Jun 26;10(7):502. doi: 10.1038/s41419-019-1741-8. Cell Death Dis. 2019. PMID: 31243265 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,975 results

Search Page

Filters